Skip to content
Research Article Open access CC BY 4.0

Prevalence of the Genetic Mutation CYP2C8*5 in Selected Ethnic Groups in Southern Ghana

Charles Brown, Christopher Larbie, Dominic Selorm Yao Amuzu

International Journal of Biochemistry Research & Review · pp. 1–9 · Published 7 Jun 2016

10.9734/IJBCRR/2016/25680

Abstract

Aim: The study determined prevalence of clinically relevant CYP2C8*5 polymorphism in 80 unrelated individuals, from selected ethnic groups in Southern Ghana. Medical history on adverse drug reactions of the subjects and level of dependency on drugs metabolized by CYP2C8 enzyme was obtained by questionnaire. Allele Specific-PCR analyses were used to genotype CYP2C8*5 alleles in the study subjects. Results: Allelic frequency for CYP2C8*5 was 83.75% which was statistically significant (p<0.05). There was no significant difference (p> 0.05) in the prevalence of CYP2C8*5 allele within the ethnic groups. Also, there was no significant association (p >0.05) between CYP2C8*5 allele and reported ADRs. Many (88.75%) of the study subjects depended highly (>1-3x in a year) on drugs metabolized by CYP2C8. Conclusions: The high prevalence of CYP2C8*5 determined in the study population may indicate a high risk of toxicity in using drugs metabolize by CYP2C8 since CYP2C8*5 mutants have been reported to have a reduced enzymatic activity. This is the first reported study on prevalence of CYP2C8*5 in Ghanaians.

CYP2C8 mutation drug toxicity artesunate amodiaquine chloroquine malaria

References (26)

  1. 1 Pyrimethamine and Proguanil Resistance-Conferring Mutations in Plasmodium falciparum Dihydrofolate Reductase: Polymerase Chain Reaction Methods for Surveillance in Africa [DOI]
  2. 2 Effects of Obesity on Pharmacokinetics [DOI]
  3. 3 Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid [DOI]
  4. 4 Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8.
  5. 5 Distribution of Soluble Epoxide Hydrolase and of Cytochrome P450 2C8, 2C9, and 2J2 in Human Tissues [DOI]
  6. 6 Cytochrome P450 2C8: Substrates, inhibitors, pharmacogenetics, and clinical relevance [DOI]
  7. 7 Pharmacokinetic Considerations in Obesity [DOI]
  8. 8 Antimicrobial Dosing in Obese Patients [DOI]
  9. 9 Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. [DOI]
  10. 10 Amodiaquine Metabolism is Impaired by Common Polymorphisms in CYP2C8: Implications for Malaria Treatment in Africa [DOI]
  11. 11 A Significant Role of Human Cytochrome P450 2C8 in Amiodarone N-Deethylation: An Approach to Predict the Contribution with Relative Activity Factor [DOI]
  12. 12 Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms [DOI]
  13. 13 Biochemical Characterization of the Human Liver Cytochrome P450 Arachidonic Acid Epoxygenase Pathway [DOI]
  14. 14 Differential expression and function of CYP2C isoforms in human intestine and liver [DOI]
  15. 15 Clinical Pharmacokinetics of Cerivastatin [DOI]
  16. 16 A 2.4-Megabase Physical Map Spanning the CYP2C Gene Cluster on Chromosome 10q24 [DOI]
  17. 17 Participation of CYP2C8 in retinoic acid 4-hydroxylation in human hepatic microsomes [DOI]
  18. 18 Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population [DOI]
  19. 19 GENETIC POLYMORPHISMS OF CYP2C8 IN JAPANESE POPULATION [DOI]
  20. 20 CYP2C8 polymorphism frequencies among malaria patients in Zanzibar [DOI]
  21. 21 Distinction between Human Cytochrome P450 (CYP) Isoforms and Identification of New Phosphorylation Sites by Mass Spectrometry [DOI]
  22. 22 Short communication: High prevalence of the cytochrome P450 2C8*2 mutation in Northern Ghana [DOI]
  23. 23 Amodiaquine-associated adverse effects after inadvertent overdose and after a standard therapeutic dose [DOI]
  24. 24 Genetic polymorphisms in diabetes: Influence on therapy with oral antidiabetics [DOI]
  25. 25 Five Novel Single Nucleotide Polymorphisms in the CYP2C8 Gene, One of which Induces a Frame-shift [DOI]
  26. 26 The Human CYP2C Locus: A Prototype for Intergenic and Exon Repetition Splicing Events [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

48

Page views

0

PDF downloads

36

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.